Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bimagrumab (Anti-ACVR2B Reference Antibody) is a human monoclonal antibody targeting the activin type II receptor (ActRII), exhibiting binding affinities (K D) of 1.7 pM for ActRIIB and 434 pM for ActRIIA, respectively. It is employed in the study of pathological muscle loss and weakness [1] [2].
Description | Bimagrumab (Anti-ACVR2B Reference Antibody) is a human monoclonal antibody targeting the activin type II receptor (ActRII), exhibiting binding affinities (K D) of 1.7 pM for ActRIIB and 434 pM for ActRIIA, respectively. It is employed in the study of pathological muscle loss and weakness [1] [2]. |
Molecular Weight | N/A |
CAS No. | 1356922-05-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bimagrumab 1356922-05-8 inhibitor inhibit